Cited by 2,948Ocular Oncology and TreatmentsCancer-related Molecular PathwaysRetinal Development and Disorders

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

Open access
Friend, Stephen H., Bernards, Rene, Rogelj, Snezna, Weinberg, Robert A., Rapaport, Joyce M., Albert, Daniel M., Dryja, Thaddeus P.·1986·Nature

Abstract

The genomes of various tumour cells contain mutant oncogenes that act dominantly, in that their effects can be observed when they are introduced into non-malignant cells. There is evidence for another class of oncogenes, in which tumour-predisposing mutations are recessive to wild-type alleles. Retinoblastoma is a prototype biological model for the study of such recessive oncogenes. This malignant tumour, which arises in the eyes of children, can be explained as the result of two distinct genetic changes, each causing loss of function of one of the two homologous copies at a single genetic locus, Rb, assigned to the q14 band of human chromosome 13. Mutations affecting this locus may be inherited from a parent, may arise during gametogenesis or may occur somatically. Those who inherit a mutant allele at this locus have a high incidence of non-ocular, second tumours, almost half of which are osteosarcomas believed to be caused by the same mutation. Here we describe the isolation of a complementary DNA segment that detects a chromosomal segment having the properties of the gene at this locus. The gene is expressed in many tumour types, but no RNA transcript has been found in retinoblastomas and osteosarcomas. The cDNA fragment detects a locus spanning at least 70 kilobases (kb) in human chromosome band 13q14, all or part of which is frequently deleted in retinoblastomas and osteosarcomas.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/323643a0

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 43 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. [8]Knudson, A. G. Jr Proc. natn. Acad. Sci. U.S.A. 68, 820–823 (1971).
  2. [25]Hansen, M. F. et al. Proc. natn. Acad. Sci. U.S.A. 82, 6216-6220 (1985).
  3. [36]Comings, D. E. Proc. natn. Acad. Sci. U.S.A. 70, 3324-3328 (1973).

Cited by

Sorted by citations

Authors
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P.
Affiliations
  • Harvard University (US)
  • Whitehead Institute for Biomedical Research (US)
  • Massachusetts Eye and Ear Infirmary (US)
Venue
Nature
Published
1986-10
Volume
323
Issue
6089
Pages
643-646
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2099742439
Cited by
2,948
References
43
Citations by year
2026: 21 · 2025: 30 · 2024: 26 · 2023: 41 · 2022: 47 · 2021: 63 · 2020: 55 · 2019: 47 · 2018: 52 · 2017: 47 · 2016: 55 · 2015: 67 · 2014: 77 · 2013: 59 · 2012: 81
FWCI
166.19
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Funders
  • National Eye Institute (EY05321)
  • National Cancer Institute (CA 39826)
Topics
  • Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
Keywords
retinoblastoma, osteosarcoma, retinoblastoma gene, chromosome 13q14, cancer susceptibility, cDNA cloning, chromosomal deletion, second primary tumours, loss of heterozygosity
MeSH terms
Chromosome Deletion, Chromosome Mapping, Chromosomes, Human, Pair 13, Cloning, Molecular, DNA, DNA, Neoplasm, Genes, Recessive, Humans, Polymorphism, Restriction Fragment Length, Retina, Retinoblastoma, Osteosarcoma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review